When choosing a CRO, the intangibles make the difference
Any CRO can get you from Phase I clinical trials to FDA approval. But it's the journey, rather than the destination, that should determine your selection.
Accelovance is an award-winning, niche Contract Research Organization (CRO) focused primarily in oncology, vaccines, and general medicine. Accelovance provides a full complement of clinical services for the pharmaceutical and biotech industries including the management and implementation of Phase I-IV clinical trials.
Accelovance has been honored as a Best CRO ViE Award winner by industry leaders three of the last five years, after being evaluated against global CROs for quality of services, performance, client satisfaction, Sponsor relationships, and the overall value brought to study Sponsors. Accelovance is known within the industry for its experience in managing clinical trials, for successful clinical oversight, patient enrollment and retention, and for providing full service solutions to Sponsors. Satisfied Sponsors and repeat business are a testament to the effectiveness of our approach.
Accelovance blends conventional tactics with innovative ideas for a comprehensive strategy to find the RIGHT patient/subject for your study.
As a patient-centric organization, Accelovance's Clinical Call Center uses clinically trained Call Center Agents who work seamlessly with clinical sites enrolling patients, Sponsors, and/or CROs.